Publication date | Issuer | Person discharging managerial responsibilities | Position | Closely associated | Nature of transaction | Instrument name | Intrument type | ISIN | Transaction date | Volume | Unit | Price | Currency | Status | Details |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/2022 | AroCell AB (publ) | Max Pihlqvist | Member of the Board of Directors | Inheritance received | AroCell AB (publ) | Share | SE0003883990 | 09/12/2022 | 2,060,696 | Quantity | 0.00 | SEK | Notification | ||
16/02/2022 | AroCell AB (publ) | Max Pihlqvist | Member of the Board of Directors | Disposal | AroCell AB TR | Subcription warrant | SE0017483357 | 14/02/2022 | 73,458 | Quantity | 0.002 | SEK | Notification | ||
10/01/2019 | IDL Biotech AB | Max Pihlqvist | Styrelseledamot/suppleant | Yes | Subscription | IDL Biotech B | Share | SE0000514747 | 10/01/2019 | 2,916,666 | Quantity | 1.20 | SEK | Notification | |
09/12/2018 | IDL Biotech AB | Max Pihlqvist | Styrelseledamot/suppleant | Yes | Intra-group transaction acquisition | IDL Biotech B | Share | SE0000514747 | 06/12/2018 | 5,500,000 | Quantity | 2.70 | SEK | Notification | |
09/12/2018 | IDL Biotech AB | Max Pihlqvist | Styrelseledamot/suppleant | Yes | Intra-group transaction disposal | IDL BIOTECH B | Share | SE0000514747 | 06/12/2018 | 5,500,000 | Quantity | 2.70 | SEK | Notification | |
28/11/2018 | IDL Biotech AB | Max Pihlqvist | Styrelseledamot/suppleant | Acquisition | ID Biotech AB | BTA | SE0011896356 | 27/11/2018 | 63,600 | Quantity | 1.20 | SEK | Notification |